Satralizumab Biosimilar – Research Grade [ICH5106]

ichorbio’s Satralizumab Biosimilar is for Research Use Only (RUO) and not for therapeutic use.

IL-6R

This biosimilar is available in the following sizes:
1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Human IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa

CHO Cells

Human

Uses the same sequence as the therapeutic antibody Satralizumab

Detects human IL-6R. This non-therapeutic antibody uses a similar sequence to the therapeutic antibody Satralizumab.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

5mg/ml

Sterile, preservative-free, solution in PBS. BSA and Azide free.

>95% by SDS-PAGE

≤ 1.0 EU/mg as determined by the LAL method

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.